Russell Investments Group, Ltd. - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 117 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$17,467,000
-33.3%
330,680
-22.6%
0.04%
-34.5%
Q2 2020$26,187,000
+21.7%
427,430
+12.4%
0.06%
+3.6%
Q1 2020$21,509,000
+136.1%
380,433
+137.7%
0.06%
+229.4%
Q4 2019$9,109,000
+216.5%
160,024
+198.1%
0.02%
+183.3%
Q3 2019$2,878,000
+192.8%
53,683
+225.9%
0.01%
+200.0%
Q2 2019$983,000
-15.3%
16,471
-11.3%
0.00%0.0%
Q1 2019$1,160,000
-21.0%
18,579
-23.4%
0.00%
-33.3%
Q4 2018$1,469,000
+30.3%
24,258
+26.0%
0.00%
+50.0%
Q3 2018$1,127,000
-3.0%
19,254
-25.7%
0.00%0.0%
Q2 2018$1,162,000
+169.6%
25,917
+166.1%
0.00%
+100.0%
Q1 2018$431,000
+656.1%
9,740
+639.6%
0.00%
Q4 2017$57,000
-76.1%
1,317
-74.3%
0.00%
Q3 2017$238,000
-86.0%
5,118
-85.1%
0.00%
-100.0%
Q2 2017$1,697,000
-10.1%
34,266
-0.5%
0.00%0.0%
Q1 2017$1,887,000
+13.8%
34,451
+13.8%
0.00%0.0%
Q4 2016$1,658,00030,2800.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q2 2020
NameSharesValueWeighting ↓
JW Asset Management, LLC 73,649$3,646,0002.32%
Stonepine Capital Management, LLC 59,878$2,965,0001.60%
NORTHPOINTE CAPITAL LLC 109,644$5,428,0000.57%
Elk Creek Partners, LLC 145,406$7,199,0000.47%
TFS CAPITAL LLC 18,208$901,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 161,671$8,004,0000.35%
Ativo Capital Management LLC 19,592$970,0000.26%
Matarin Capital Management, LLC 57,034$2,823,753,0000.26%
ISTHMUS PARTNERS, LLC 16,505$817,0000.24%
Stanley-Laman Group, Ltd. 12,546$621,0000.17%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders